Abstract
ObjectiveProgrammed cell death protein 1 (PD-1) checkpoint inhibition and adoptive cellular therapy have had limited success in patients with microsatellite stable colorectal cancer liver metastases (CRLM). We sought to evaluate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have